HM
Hal Mintz
10% Owner

Hal Mintz insider trades: Celsus Therapeutics (CLTX) stock buys and sales

10% Owner, Celsus Therapeutics Last trade Apr 15, 2014 8 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2010
3
Companies
last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Hal reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 15, 2014CLTX↑ Buy$101K
Apr 11, 2014CLTX↑ Buy$14K
Apr 8, 2014CLTX↑ Buy$383K
Apr 2, 2014CLTX↑ Buy$61K
Apr 1, 2014CLTX↑ Buy$48K
Mar 31, 2014CLTX↑ Buy$66K
Mar 27, 2014CLTX↑ Buy$108K
Mar 24, 2014CLTX↑ Buy$76K
Aug 18, 2010SNGX↓ Sell$46K
Aug 18, 2010SNGX↑ Buy$38K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Hal Mintz's insider trades

Hal Mintz is a 10% owner of Celsus Therapeutics (CLTX). Since Aug 18, 2010, Hal has reported 9 open-market purchases worth $895K and 1 sale worth $46K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.